3′-Sialyllactose ameliorates antibiotic-associated diarrhea by shaping unique gut microbiota and metabolite composition
Journal of Dairy Science · 2026-03 · 109 (3) · 2108-2121
DOI: 10.3168/jds.2025-27362 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Dairy Science, 2026-03. Verfasst von Yi Shan und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Food Engineering, Harbin University, Harbin 150086, China. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Oligosaccharides, Gastrointestinal Microbiome, Diarrhea. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
3'-Sialyllactose (3'-SL) is a naturally occurring prebiotic in milk, known to regulate intestinal microbiota and prevent diseases. However, the mechanisms through which 3'-SL alleviates antibiotic-associated diarrhea remain poorly understood. In this study, an antibiotic-associated diarrhea model was established through the co-administration of ampicillin and neomycin. The effects of 3'-SL supplementation on diarrhea phenotype, inflammation, intestinal permeability, and barrier function were examined in antibiotic-associated diarrhea-model mice. Moreover, gut microbiota composition, metabolite profiles, and their alterations were analyzed using genomic and metabolomic approaches. The results demonstrate that 3'-SL increased body weight and aquaporin (AQP) 3 and AQP4 levels but reduced diarrhea rate, cecal mass, and fecal water content in the model mice, indicating its therapeutic effect on diarrhea. Furthermore, 3'-SL reduced serum levels of IL-6, tumor necrosis factor (TNF)-α, and IL-1β, while increasing IL-10 levels in the mice. Moreover, 3'-SL reduced intestinal permeability by enhancing both the mechanical barrier (ZO-1 and occludin mRNA expression) and the chemical barrier (MUC2 mRNA and protein expression) in the mice. 16S rRNA analysis revealed that mice in the 3'-SL group exhibited greater abundances of Akkermansia, Bacteroides, and Dubosiella, along with a reduced relative abundance of the diarrhea-associated bacterium Alloprevotella. Furthermore, metabolomics analysis indicated that 3'-SL promoted enrichment of purine metabolism, pyrimidine metabolism, nucleotide metabolism, and the pentose phosphate pathway, which may be associated with diarrhea development, inflammation amelioration, and barrier regulation. In conclusion, our findings suggest that 3'-SL ameliorates antibiotic-associated diarrhea by modulating gut microbiota and metabolite profiles.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Food Engineering, Harbin University, Harbin 150086, China.
- Heilongjiang Green Food Science Research Institute, Northeast Agricultural University, Harbin 150086, China.
- Harbin Institute of Technology, Harbin 150000, China.
- School of Food Engineering, Harbin University, Harbin 150086, China. Electronic address: miaomiao_0000@126.com.
Zitieren
APA
Shan, Y., Huang, X., Han, X., Yang, Y., & Zheng, M. (2026). 3′-Sialyllactose ameliorates antibiotic-associated diarrhea by shaping unique gut microbiota and metabolite composition. Journal of Dairy Science, 109(3), 2108-2121. https://doi.org/10.3168/jds.2025-27362
Vancouver
Shan Y, Huang X, Han X, Yang Y, Zheng M. 3′-Sialyllactose ameliorates antibiotic-associated diarrhea by shaping unique gut microbiota and metabolite composition. Journal of Dairy Science. 2026;109(3):2108-2121. doi:10.3168/jds.2025-27362
BibTeX
@article{Shan2026,
author = {Shan, Yi and Huang, Xiaolin and Han, Xue and Yang, Yuju and Zheng, Miaomiao},
title = {3′-Sialyllactose ameliorates antibiotic-associated diarrhea by shaping unique gut microbiota and metabolite composition},
journal = {Journal of Dairy Science},
year = {2026},
volume = {109},
number = {3},
pages = {2108--2121},
doi = {10.3168/jds.2025-27362}
}
EUVIMED